XI
NVO

XXEC Inc’s Novo Nordisk NVO Stock Holding History

XXEC Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29M Buy
545,020
+452,185
+487% +$21.4M 5.08% 10
2025
Q4 		$4.72M Sell
92,835
-6,240
-6% -$319K 4.72% 11
2025
Q3 		$5.5M Buy
99,075
+20,890
+27% +$1.22M 4.64% 10
2025
Q2 		$5.4M Buy
78,185
+21,756
+39% +$1.48M 4.34% 11
2025
Q1 		$3.92M Buy
56,429
+38,102
+208% +$3.15M 3.4% 13
2024
Q4 		$1.58M Buy
+18,327
New +$1.98M 1.31% 21

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

XXEC Inc's NVO Position: Q1 2026 in Review

XXEC Inc increased its Novo Nordisk (NVO) stake by 487% in Q1 2026, buying an estimated $21.4M and bringing the position to 545,020 shares worth $29M. The position accounts for 5.08% of the portfolio, ranked #10.

XXEC Inc first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • XXEC Inc held 545,020 shares of Novo Nordisk worth $29M as of Q1 2026.
  • XXEC Inc bought 452,185 Novo Nordisk shares in Q1 2026, an estimated $21.4M.
  • Novo Nordisk made up 5.08% of XXEC Inc's portfolio in Q1 2026, its #10 holding.
  • XXEC Inc first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on XXEC Inc's 13F filing for Q1 2026, filed 24 Apr 2026.